4 results  1 of 1 

1 급성신손상을 동반한 올메사르탄 유발성 장병증 1예
Moo Jin Kang, Kyung Hwa Min, Hyung Wook Kim, Su Bum Park, Dae Hwan Kang, Cheol Woong Choi, Su Jin Kim, Hyeong Seok Nam, Dae Gon Ryu
Korean J Gastroenterol.2022;79(3):130-134.   Published online 2022 March 25     DOI: http://dx.doi.org/10.4166/kjg.2022.007
      
2 Pharmacokinetics and bioequivalence of two different 20 mg olmesartan tablets: A randomized, single-dose, two-period crossover study in healthy Korean male volunteers
Jieon Lee, AnHye Kim, Kyung-Sang Yu, Jae-Yong Chung, Sung-Vin Yim, Bo-Hyung Kim
Transl Clin Pharmacol.2015;23(2):49-53.   Published online 2015 December 15     DOI: http://dx.doi.org/10.12793/tcp.2015.23.2.49
   
3 Bioequivalence and Dose Proportionality of Olmesartan Medoxomil Formulations
Sung Kweon Cho, Choon Ok Kim, Su Hyun Yu, Eun Sil Oh, Seong Bok Jang, Yoong Sik Park, Kyunghee Cho, Jae-Yong Chung
J Korean Soc Clin Pharmacol Ther.2012;20(2):145-154.   Published online 2012 December 31     DOI: http://dx.doi.org/10.12793/jkscpt.2012.20.2.145
      
4 Inhibitory Effects of Olmesartan on Catecholamine Secretion from the Perfused Rat Adrenal Medulla
Hyo-Jeong Lim, Sang-Yong Kim, Dong-Yoon Lim
Korean J Physiol Pharmacol.2010;14(4):241-248.   Published online 2010 February 18     DOI: http://dx.doi.org/10.4196/kjpp.2010.14.4.241
   

 1 of 1